Keyphrases
Cancer Patients
25%
Chimeric Antigen Receptor T Cells (CAR-T)
100%
Customization
25%
Expression Level
25%
Gene Regulation
25%
Immune Effector Cells
25%
Inducing Agents
25%
Minimal Promoter
100%
Primary T Cells
25%
Promoter Elements
100%
Promoter Strength
25%
Spatial Control
25%
Synthetic Promoter
100%
T Cell Activation
25%
T-system
25%
Temporal Control
25%
Therapeutic Approaches
25%
Transgene Expression
50%
Tumor
50%
Tumor Microenvironment
100%
Medicine and Dentistry
Cell Function
20%
Chimeric Antigen Receptor
80%
Chimeric Antigen Receptor T-Cell Therapy
20%
Effector Cell
20%
Gene Control
20%
Malignant Neoplasm
20%
Neoplasm
40%
Promoter Region
100%
T Cell
20%
Transgene
40%
Tumor Microenvironment
100%
Biochemistry, Genetics and Molecular Biology
Cell Function
25%
Chimeric Antigen Receptor
100%
Gene Control
25%
Pribnow Box
100%
Promoter Region
100%
T Cell
25%
Transgene
50%
Immunology and Microbiology
Cell Function
20%
Chimeric Antigen Receptor
80%
Chimeric Antigen Receptor T-Cell Therapy
20%
Effector Cell
20%
Gene Control
20%
Promoter Region
100%
T Cell
20%
Transgene
40%
Neuroscience
Cell Function
20%
Chimeric Antigen Receptor
80%
Gene Control
20%
Promoter Region
100%
T Cell
20%
Transgene
40%
Pharmacology, Toxicology and Pharmaceutical Science
Chimeric Antigen Receptor
100%
Malignant Neoplasm
25%
Neoplasm
50%
Tumor Microenvironment
100%